Exact Mass: 604.3697

Exact Mass Matches: 604.3697

Found 98 metabolites which its exact mass value is equals to given mass value 604.3697, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PA(10:0/18:1(12Z)-O(9S,10R))

[(2R)-3-(decanoyloxy)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C31H57O9P (604.374)


PA(10:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/10:0)

[(2R)-2-(decanoyloxy)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C31H57O9P (604.374)


PA(18:1(12Z)-O(9S,10R)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/10:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(10:0/18:1(9Z)-O(12,13))

[(2R)-3-(decanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C31H57O9P (604.374)


PA(10:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/10:0)

[(2R)-2-(decanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C31H57O9P (604.374)


PA(18:1(9Z)-O(12,13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/10:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Periplocoside M

Periplocoside M

C34H52O9 (604.3611)


   
   

3beta-p-Hydroxybenzoyldehydrotumulosic acid

3beta-p-Hydroxybenzoyldehydrotumulosic acid

C38H52O6 (604.3764)


   

Tiacumicin A

Tiacumicin A

C34H52O9 (604.3611)


   
   

(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C

(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C

C38H52O6 (604.3764)


   

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

C38H52O6 (604.3764)


   

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

C38H52O6 (604.3764)


   
   

Xanthochymol

Xanthochymol

C38H52O6 (604.3764)


   

14beta-hydrogen-(20S,22R)-22,26-epoxy-27-[(beta-glucopyranosyl)oxy]ergosta-2,4,6,24-tetraene-1,26-dione|baimantuoluoside H

14beta-hydrogen-(20S,22R)-22,26-epoxy-27-[(beta-glucopyranosyl)oxy]ergosta-2,4,6,24-tetraene-1,26-dione|baimantuoluoside H

C34H52O9 (604.3611)


   

biselyngbyaside

biselyngbyaside

C34H52O9 (604.3611)


   

(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate

(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate

C38H52O6 (604.3764)


   

11beta-Alcohol, Me ester-Viridominic acid A

11beta-Alcohol, Me ester-Viridominic acid A

C34H52O9 (604.3611)


   
   

(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B

(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B

C38H52O6 (604.3764)


   

Gly Leu Arg Val Phe

Gly Leu Arg Val Phe

C29H48N8O6 (604.3697)


   

2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene

2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene

C38H52O6 (604.3764)


   

Spinosyn D 17-pseudoaglycone

Spinosyn D 17-pseudoaglycone

C34H52O9 (604.3611)


   

PA(10:0/18:1(12Z)-O(9S,10R))

PA(10:0/18:1(12Z)-O(9S,10R))

C31H57O9P (604.374)


   

PA(18:1(12Z)-O(9S,10R)/10:0)

PA(18:1(12Z)-O(9S,10R)/10:0)

C31H57O9P (604.374)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)


   

2-[[(2R)-3-acetyloxy-2-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-acetyloxy-2-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)


   

2-[[(2R)-2-acetyloxy-3-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-acetyloxy-3-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)


   

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)


   

[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14-trienyl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14-trienyl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C31H57O9P (604.374)


   

(4S,5E,9E,11S,13E,15E,18R)-4-[(2R,3R,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dienyl]-1-oxacyclooctadeca-5,9,13,15-tetraen-2-one

(4S,5E,9E,11S,13E,15E,18R)-4-[(2R,3R,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dienyl]-1-oxacyclooctadeca-5,9,13,15-tetraen-2-one

C34H52O9 (604.3611)


   

MGDG O-25:7

MGDG O-25:7

C34H52O9 (604.3611)


   
   

PA O-16:0/12:3;O2

PA O-16:0/12:3;O2

C31H57O9P (604.374)


   

PA O-20:0/8:3;O2

PA O-20:0/8:3;O2

C31H57O9P (604.374)


   

PA O-28:3;O2

PA O-28:3;O2

C31H57O9P (604.374)


   

PA P-16:0/12:2;O2

PA P-16:0/12:2;O2

C31H57O9P (604.374)


   

PA P-20:0/8:2;O2

PA P-20:0/8:2;O2

C31H57O9P (604.374)


   

PA P-20:1/8:1;O2

PA P-20:1/8:1;O2

C31H57O9P (604.374)


   

PA 20:1/8:1;O

PA 20:1/8:1;O

C31H57O9P (604.374)


   

PA 22:0/6:2;O

PA 22:0/6:2;O

C31H57O9P (604.374)


   
   

PEth 26:2;O

PEth 26:2;O

C31H57O9P (604.374)


   
   

ST 28:3;O3;GlcA

ST 28:3;O3;GlcA

C34H52O9 (604.3611)


   

ST 28:4;O4;Hex

ST 28:4;O4;Hex

C34H52O9 (604.3611)


   

(3s,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,13ar,13bs)-7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(3s,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,13ar,13bs)-7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)


   

3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-(2-isopropyl-5-methylhex-4-en-1-yl)-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-(2-isopropyl-5-methylhex-4-en-1-yl)-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)


   

2-[2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)


   

3beta-p-hydroxybenzoyldehydrotumtlosic acid

NA

C38H52O6 (604.3764)


{"Ingredient_id": "HBIN008331","Ingredient_name": "3beta-p-hydroxybenzoyldehydrotumtlosic acid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3β-p-hydroxybenzoyldehydrotumulosicacid

NA

C38H52O6 (604.3764)


{"Ingredient_id": "HBIN008332","Ingredient_name": "3\u03b2-p-hydroxybenzoyldehydrotumulosicacid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15813","TCMID_id": "9822","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)


   

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)


   

(1s,2r,8r,10r,11r,15s,16s,18r)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-10-hydroxy-2,7,7,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-18-yl (2r)-2-methylbutanoate

(1s,2r,8r,10r,11r,15s,16s,18r)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-10-hydroxy-2,7,7,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-18-yl (2r)-2-methylbutanoate

C34H52O9 (604.3611)


   

(3r,3as,5ar,5br,6r,7s,7ar,9s,11as,11br,12r,13ar,13bs)-12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

(3r,3as,5ar,5br,6r,7s,7ar,9s,11as,11br,12r,13ar,13bs)-12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)


   

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-[(2s)-2-isopropyl-5-methylhex-4-en-1-yl]-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-[(2s)-2-isopropyl-5-methylhex-4-en-1-yl]-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)


   

(2s)-n-[(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-[(2s)-2-(dimethylamino)-n,3-dimethylbutanamido]-n,3-dimethylbutanamide

(2s)-n-[(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-[(2s)-2-(dimethylamino)-n,3-dimethylbutanamido]-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)


   

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)


   

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)


   

(3r,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

(3r,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)


   

3-(acetyloxy)-15-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

3-(acetyloxy)-15-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)


   

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1r)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1r)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)


   

1-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

1-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)


   

2-[(7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[(7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)


   

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

n-(1-{[1-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-1-oxo-3-phenylpropan-2-yl](methyl)carbamoyl}-2-methylpropyl)-2-(dimethylamino)-n,3-dimethylbutanamide

n-(1-{[1-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-1-oxo-3-phenylpropan-2-yl](methyl)carbamoyl}-2-methylpropyl)-2-(dimethylamino)-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)


   

(4as,6ar,6br,10s,12ar,14bs)-6a-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6ar,6br,10s,12ar,14bs)-6a-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C38H52O6 (604.3764)


   

7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)


   

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5s,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5s,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

(3r,4r,5s,6r)-6-{[(4e,6e,10e,14z,16e)-2,9-diethyl-12-hydroxy-5,7,11,17-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl acetate

(3r,4r,5s,6r)-6-{[(4e,6e,10e,14z,16e)-2,9-diethyl-12-hydroxy-5,7,11,17-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl acetate

C34H52O9 (604.3611)


   

1-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

1-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)


   

7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)


   

3-(acetyloxy)-15-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

3-(acetyloxy)-15-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)


   

6-[1-(9-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

6-[1-(9-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)


   

(2s,4as,6as,6br,8ar,10r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,6a,6b,9,9,12a-hexamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-2-carboxylic acid

(2s,4as,6as,6br,8ar,10r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,6a,6b,9,9,12a-hexamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-2-carboxylic acid

C38H52O6 (604.3764)


   

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)


   

12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)


   

2-[(1-{1-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]ethyl}-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl)oxy]-4-methoxy-6-methyl-2,6-dihydropyran-3-one

2-[(1-{1-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]ethyl}-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl)oxy]-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)


   

(6r)-6-[(1s)-1-[(1r,3as,3bs,7r,9s,9ar,9bs,11as)-9-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

(6r)-6-[(1s)-1-[(1r,3as,3bs,7r,9s,9ar,9bs,11as)-9-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)